Plus Therapeutics News - PSTV

Company Name	Stock Ticker Symbol	Market	Type
Plus Therapeutics Inc	PSTV	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.60	04:00:01

Open Price	Low Price	High Price	Close Price	Prev Close
				1.60

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	07:00	GLOBE	Plus Therapeutics Receives $3 Million Award Recommendation..
3/08/2024	16:30	EDGAR2	Form S-1/A - General form for registration of securities..
3/05/2024	16:04	EDGAR2	Form 8-K - Current report
3/05/2024	16:01	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/26/2024	18:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	18:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/15/2023	17:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	16:22	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/22/2023	16:08	EDGAR2	Form S-1 - General form for registration of securities under..
11/21/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/20/2023	07:01	EDGAR2	Form 8-K - Current report
11/17/2023	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/15/2023	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/13/2023	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/08/2023	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/31/2023	16:55	EDGAR2	Form 8-K - Current report
10/31/2023	16:06	EDGAR2	Form 8-K - Current report
10/31/2023	16:02	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/15/2023	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/12/2023	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/11/2023	07:00	GLOBE	Plus Therapeutics Receives $1.9 Million Advance Payment from..
9/08/2023	07:00	GLOBE	Plus Therapeutics Enters into License Agreement for..
9/05/2023	07:00	GLOBE	Plus Therapeutics Initiates Part B of ReSPECT-LM Phase 1/2a..
8/30/2023	07:00	GLOBE	Plus Therapeutics to Present at the H.C. Wainwright 25th..
8/21/2023	06:05	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/2023	16:12	EDGAR2	Form 8-K - Current report
8/14/2023	16:05	GLOBE	Plus Therapeutics Reports Second Quarter 2023 Financial..
8/14/2023	16:02	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/2023	06:30	GLOBE	Plus Therapeutics Reports ReSPECT-LM Phase 1 Trial Data at..
8/09/2023	07:55	EDGAR2	Form S-1 - General form for registration of securities under..
8/08/2023	16:05	GLOBE	Plus Therapeutics to Announce Second Quarter 2023 Financial..
8/08/2023	11:22	GLOBE	Plus Therapeutics Announces Key Opinion Leader Roundtable on..
8/03/2023	07:00	GLOBE	Plus Therapeutics to Present at the Canaccord Genuity 43rd..
7/27/2023	16:05	GLOBE	Plus Therapeutics Strengthens Clinical Program with the..
7/27/2023	07:00	GLOBE	Plus Therapeutics to Present at the 2023 SNO/ASCO CNS Cancer..
7/13/2023	07:00	GLOBE	Plus Therapeutics to Present at the 2nd Annual Targeted..
6/29/2023	07:00	GLOBE	Plus Therapeutics Reports Positive Interim Updates from Two..
6/14/2023	07:00	GLOBE	Plus Therapeutics to Participate in the 2023 Healthcare..
6/08/2023	07:00	GLOBE	Plus Therapeutics Announces Participation at Upcoming SNO..
6/01/2023	07:00	GLOBE	Plus Therapeutics Provides Company Update Today
5/30/2023	07:00	GLOBE	Plus Therapeutics Announces Topline Results from Recurrent..
5/25/2023	07:00	GLOBE	Plus Therapeutics to Present at the 2023 Virtual June..
5/16/2023	07:00	GLOBE	Plus Therapeutics Regains Compliance with Nasdaq Listing..
5/12/2023	07:00	GLOBE	Plus Therapeutics to Present in EndBrainCancer Initiative..